N,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)-1,3-thiazol-2-amine;4-methyl-2-(2-methylsulfanylpyrimidin-5-yl)-1,3-thiazole;N-methyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;[4-(4-methyl-1,3-thiazol-2-yl)phenyl]thiourea;5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N-[5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-yl]acetamide

C66H71N25OS10 — CID 158120250

IUPACN,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)-1,3-thiazol-2-amine;4-methyl-2-(2-methylsulfanylpyrimidin-5-yl)-1,3-thiazole;N-methyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;[4-(4-methyl-1,3-thiazol-2-yl)phenyl]thiourea;5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N-[5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-yl]acetamide
SMILESCC(=O)Nc1ncc(-c2nc(C)cs2)cn1.CNc1ncc(-c2nc(C)cs2)cn1.CSc1ncc(-c2nc(C)cs2)cn1.Cc1csc(-c2ccc(NC(N)=S)cc2)n1.Cc1csc(-c2cnc(N(C)C)nc2)n1.Cc1csc(-c2cnc(N(C)C)s2)n1.Cc1csc(-c2cnc(N)nc2)n1
InChIInChI=1S/C11H11N3S2.C10H10N4OS.C10H12N4S.C9H10N4S.C9H11N3S2.C9H9N3S2.C8H8N4S/c1-7-6-16-10(13-7)8-2-4-9(5-3-8)14-11(12)15;1-6-5-16-9(13-6)8-3-11-10(12-4-8)14-7(2)15;1-7-6-15-9(13-7)8-4-11-10(12-5-8)14(2)3;1-6-5-14-8(13-6)7-3-11-9(10-2)12-4-7;1-6-5-13-8(11-6)7-4-10-9(14-7)12(2)3;1-6-5-14-8(12-6)7-3-10-9(13-2)11-4-7;1-5-4-13-7(12-5)6-2-10-8(9)11-3-6/h2-6H,1H3,(H3,12,14,15);3-5H,1-2H3,(H,11,12,14,15);4-6H,1-3H3;3-5H,1-2H3,(H,10,11,12);4-5H,1-3H3;3-5H,1-2H3;2-4H,1H3,(H2,9,10,11)
InChIKeyFRNDCVMELDEMEW-UHFFFAOYSA-N
MW1551.14 g/mol
LogP15.33
Rot. Bonds13

About N,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)-1,3-thiazol-2-amine;4-methyl-2-(2-methylsulfanylpyrimidin-5-yl)-1,3-thiazole;N-methyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;[4-(4-methyl-1,3-thiazol-2-yl)phenyl]thiourea;5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N-[5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-yl]acetamide

N,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)-1,3-thiazol-2-amine;4-methyl-2-(2-methylsulfanylpyrimidin-5-yl)-1,3-thiazole;N-methyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;[4-(4-methyl-1,3-thiazol-2-yl)phenyl]thiourea;5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N-[5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-yl]acetamide (PubChem CID 158120250) has the molecular formula C66H71N25OS10 and a molecular weight of 1551.14 g/mol. Its IUPAC name is N,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)-1,3-thiazol-2-amine;4-methyl-2-(2-methylsulfanylpyrimidin-5-yl)-1,3-thiazole;N-methyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;[4-(4-methyl-1,3-thiazol-2-yl)phenyl]thiourea;5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N-[5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-yl]acetamide.

Molecular Properties

Compound NameN,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)-1,3-thiazol-2-amine;4-methyl-2-(2-methylsulfanylpyrimidin-5-yl)-1,3-thiazole;N-methyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;[4-(4-methyl-1,3-thiazol-2-yl)phenyl]thiourea;5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N-[5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-yl]acetamide
PubChem CID158120250
Molecular FormulaC66H71N25OS10
Molecular Weight1551.14 g/mol
Exact Mass1549.35
IUPAC NameN,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)-1,3-thiazol-2-amine;4-methyl-2-(2-methylsulfanylpyrimidin-5-yl)-1,3-thiazole;N-methyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;[4-(4-methyl-1,3-thiazol-2-yl)phenyl]thiourea;5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N-[5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-yl]acetamide
SMILESCC(=O)Nc1ncc(-c2nc(C)cs2)cn1.CNc1ncc(-c2nc(C)cs2)cn1.CSc1ncc(-c2nc(C)cs2)cn1.Cc1csc(-c2ccc(NC(N)=S)cc2)n1.Cc1csc(-c2cnc(N(C)C)nc2)n1.Cc1csc(-c2cnc(N(C)C)s2)n1.Cc1csc(-c2cnc(N)nc2)n1
InChIInChI=1S/C11H11N3S2.C10H10N4OS.C10H12N4S.C9H10N4S.C9H11N3S2.C9H9N3S2.C8H8N4S/c1-7-6-16-10(13-7)8-2-4-9(5-3-8)14-11(12)15;1-6-5-16-9(13-6)8-3-11-10(12-4-8)14-7(2)15;1-7-6-15-9(13-7)8-4-11-10(12-5-8)14(2)3;1-6-5-14-8(13-6)7-3-11-9(10-2)12-4-7;1-6-5-13-8(11-6)7-4-10-9(14-7)12(2)3;1-6-5-14-8(12-6)7-3-10-9(13-2)11-4-7;1-5-4-13-7(12-5)6-2-10-8(9)11-3-6/h2-6H,1H3,(H3,12,14,15);3-5H,1-2H3,(H,11,12,14,15);4-6H,1-3H3;3-5H,1-2H3,(H,10,11,12);4-5H,1-3H3;3-5H,1-2H3;2-4H,1H3,(H2,9,10,11)
InChIKeyFRNDCVMELDEMEW-UHFFFAOYSA-N
XLogP15.33
TPSA343.70 Ų
H-Bond Donors5
H-Bond Acceptors33
Rotatable Bonds13
Heavy Atoms102
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001551.14
LogP ≤ 515.33
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1033

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'}

Analyze N,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)-1,3-thiazol-2-amine;4-methyl-2-(2-methylsulfanylpyrimidin-5-yl)-1,3-thiazole;N-methyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;[4-(4-methyl-1,3-thiazol-2-yl)phenyl]thiourea;5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N-[5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)-1,3-thiazol-2-amine;4-methyl-2-(2-methylsulfanylpyrimidin-5-yl)-1,3-thiazole;N-methyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;[4-(4-methyl-1,3-thiazol-2-yl)phenyl]thiourea;5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N-[5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-yl]acetamide?
The IUPAC name of N,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)-1,3-thiazol-2-amine;4-methyl-2-(2-methylsulfanylpyrimidin-5-yl)-1,3-thiazole;N-methyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;[4-(4-methyl-1,3-thiazol-2-yl)phenyl]thiourea;5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N-[5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-yl]acetamide (CID 158120250) is N,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)-1,3-thiazol-2-amine;4-methyl-2-(2-methylsulfanylpyrimidin-5-yl)-1,3-thiazole;N-methyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;[4-(4-methyl-1,3-thiazol-2-yl)phenyl]thiourea;5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N-[5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-yl]acetamide.
What is the SMILES notation for N,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)-1,3-thiazol-2-amine;4-methyl-2-(2-methylsulfanylpyrimidin-5-yl)-1,3-thiazole;N-methyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;[4-(4-methyl-1,3-thiazol-2-yl)phenyl]thiourea;5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N-[5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-yl]acetamide?
The canonical SMILES for N,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)-1,3-thiazol-2-amine;4-methyl-2-(2-methylsulfanylpyrimidin-5-yl)-1,3-thiazole;N-methyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;[4-(4-methyl-1,3-thiazol-2-yl)phenyl]thiourea;5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N-[5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-yl]acetamide is CC(=O)Nc1ncc(-c2nc(C)cs2)cn1.CNc1ncc(-c2nc(C)cs2)cn1.CSc1ncc(-c2nc(C)cs2)cn1.Cc1csc(-c2ccc(NC(N)=S)cc2)n1.Cc1csc(-c2cnc(N(C)C)nc2)n1.Cc1csc(-c2cnc(N(C)C)s2)n1.Cc1csc(-c2cnc(N)nc2)n1.
What is the InChIKey of N,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)-1,3-thiazol-2-amine;4-methyl-2-(2-methylsulfanylpyrimidin-5-yl)-1,3-thiazole;N-methyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;[4-(4-methyl-1,3-thiazol-2-yl)phenyl]thiourea;5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N-[5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-yl]acetamide?
The InChIKey is FRNDCVMELDEMEW-UHFFFAOYSA-N. The full InChI is InChI=1S/C11H11N3S2.C10H10N4OS.C10H12N4S.C9H10N4S.C9H11N3S2.C9H9N3S2.C8H8N4S/c1-7-6-16-10(13-7)8-2-4-9(5-3-8)14-11(12)15;1-6-5-16-9(13-6)8-3-11-10(12-4-8)14-7(2)15;1-7-6-15-9(13-7)8-4-11-10(12-5-8)14(2)3;1-6-5-14-8(13-6)7-3-11-9(10-2)12-4-7;1-6-5-13-8(11-6)7-4-10-9(14-7)12(2)3;1-6-5-14-8(12-6)7-3-10-9(13-2)11-4-7;1-5-4-13-7(12-5)6-2-10-8(9)11-3-6/h2-6H,1H3,(H3,12,14,15);3-5H,1-2H3,(H,11,12,14,15);4-6H,1-3H3;3-5H,1-2H3,(H,10,11,12);4-5H,1-3H3;3-5H,1-2H3;2-4H,1H3,(H2,9,10,11).
What are the key properties of N,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)-1,3-thiazol-2-amine;4-methyl-2-(2-methylsulfanylpyrimidin-5-yl)-1,3-thiazole;N-methyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;[4-(4-methyl-1,3-thiazol-2-yl)phenyl]thiourea;5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N-[5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-yl]acetamide?
N,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)-1,3-thiazol-2-amine;4-methyl-2-(2-methylsulfanylpyrimidin-5-yl)-1,3-thiazole;N-methyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;[4-(4-methyl-1,3-thiazol-2-yl)phenyl]thiourea;5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N-[5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-yl]acetamide has a molecular weight of 1551.14 g/mol, XLogP of 15.33, 13 rotatable bonds, 5 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for N,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N,N-dimethyl-5-(4-methyl-1,3-thiazol-2-yl)-1,3-thiazol-2-amine;4-methyl-2-(2-methylsulfanylpyrimidin-5-yl)-1,3-thiazole;N-methyl-5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;[4-(4-methyl-1,3-thiazol-2-yl)phenyl]thiourea;5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-amine;N-[5-(4-methyl-1,3-thiazol-2-yl)pyrimidin-2-yl]acetamide is sourced from PubChem (CID 158120250), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).